+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alpha 2 Agonist"

Neurological Disorder Drugs Market Report 2025 - Product Thumbnail Image

Neurological Disorder Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
ZANAFLEX Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ZANAFLEX Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Alpha-2 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha-2 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Alpha 2 Agonists are a class of drugs used to treat a variety of conditions related to the Central Nervous System (CNS). These drugs act on the alpha-2 adrenergic receptor, which is found in the brain and other parts of the body. Alpha 2 Agonists are used to treat conditions such as anxiety, depression, insomnia, and pain. They can also be used to treat hypertension, glaucoma, and other conditions. Alpha 2 Agonists are typically administered orally, intramuscularly, or intravenously. Common side effects of these drugs include drowsiness, dizziness, dry mouth, and constipation. The Alpha 2 Agonist market is an important part of the CNS drug market. These drugs are used to treat a variety of conditions, and are often prescribed in combination with other drugs. Some companies in the Alpha 2 Agonist market include Pfizer, Merck, GlaxoSmithKline, and Novartis. Show Less Read more